Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
European Urology Oncology|March 1, 2022
Immune Contexture and Differentiation Features Predict Outcome in Bladder CancerAnn Taber, Frederik Prip, Philippe Lamy, et al.European Urology Open Science|December 28, 2023
Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder CancerSara Kaczor Elbæk, Tine Ginnerup Andreasen, Ann Taber, et al.European Urology|September 30, 2017
Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy AnalysisKarin Birkenkamp-Demtröder, Emil Christensen, Iver Nordentoft, et al.Iscience|March 5, 2024
Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristicsMeenakshi Anurag, Trine Strandgaard, Sung Han Kim, et al.Urologic Oncology|March 13, 2021
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancerAnn Taber, Youngrok Park, Alana Lelo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.Nature Communications|September 26, 2020
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2019
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder CarcinomaEmil Christensen, Karin Birkenkamp-Demtröder, Himanshu Sethi, et al.Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.Pageof 1